The Cost-Benefit Calculus of Prevention: Analyzing High-Cost Drugs and Public Health in the Atherosclerosis Market Economic Outlook
  The Atherosclerosis Market Economic Outlook is a paradox of high financial burden and profound cost-effectiveness potential, shaping the decisions of policymakers and payers globally. The core economic challenge stems from the substantial, direct healthcare costs associated with treating the acute consequences of atherosclerosis, primarily myocardial infarction (MI) and stroke, which...
0 Commenti 0 condivisioni 13 Views 0 Anteprima